361 related articles for article (PubMed ID: 30051603)
1. PGC1β regulates multiple myeloma tumor growth through LDHA-mediated glycolytic metabolism.
Zhang H; Li L; Chen Q; Li M; Feng J; Sun Y; Zhao R; Zhu Y; Lv Y; Zhu Z; Huang X; Xie W; Xiang W; Yao P
Mol Oncol; 2018 Sep; 12(9):1579-1595. PubMed ID: 30051603
[TBL] [Abstract][Full Text] [Related]
2. miR-489 suppresses multiple myeloma cells growth through inhibition of LDHA-mediated aerobic glycolysis.
Wu H; Wang X; Wu T; Yang S
Genes Genomics; 2020 Mar; 42(3):291-297. PubMed ID: 31872383
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma.
Sheng SL; Liu JJ; Dai YH; Sun XG; Xiong XP; Huang G
FEBS J; 2012 Oct; 279(20):3898-910. PubMed ID: 22897481
[TBL] [Abstract][Full Text] [Related]
4. JMJD2A promotes the Warburg effect and nasopharyngeal carcinoma progression by transactivating LDHA expression.
Su Y; Yu QH; Wang XY; Yu LP; Wang ZF; Cao YC; Li JD
BMC Cancer; 2017 Jul; 17(1):477. PubMed ID: 28693517
[TBL] [Abstract][Full Text] [Related]
5. MiR-33b inhibits osteosarcoma cell proliferation through suppression of glycolysis by targeting Lactate Dehydrogenase A (LDHA).
Zheng XM; Xu CW; Wang F
Cell Mol Biol (Noisy-le-grand); 2018 Aug; 64(11):31-35. PubMed ID: 30213286
[TBL] [Abstract][Full Text] [Related]
6. PGC1β Regulates Breast Tumor Growth and Metastasis by SREBP1-Mediated HKDC1 Expression.
Chen X; Lv Y; Sun Y; Zhang H; Xie W; Zhong L; Chen Q; Li M; Li L; Feng J; Yao A; Zhang Q; Huang X; Yu Z; Yao P
Front Oncol; 2019; 9():290. PubMed ID: 31058090
[No Abstract] [Full Text] [Related]
7. Metabolic signature identifies novel targets for drug resistance in multiple myeloma.
Maiso P; Huynh D; Moschetta M; Sacco A; Aljawai Y; Mishima Y; Asara JM; Roccaro AM; Kimmelman AC; Ghobrial IM
Cancer Res; 2015 May; 75(10):2071-82. PubMed ID: 25769724
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor pathway promotes glycolysis by activating LDHA and suppressing LDHB in a STAT1-dependent manner in prostate cancer.
Ye Y; Yang F; Gu Z; Li W; Yuan Y; Liu S; Zhou L; Han B; Zheng R; Cao Z
J Transl Med; 2024 May; 22(1):474. PubMed ID: 38764020
[TBL] [Abstract][Full Text] [Related]
9. Lactate dehydrogenase A negatively regulated by miRNAs promotes aerobic glycolysis and is increased in colorectal cancer.
Wang J; Wang H; Liu A; Fang C; Hao J; Wang Z
Oncotarget; 2015 Aug; 6(23):19456-68. PubMed ID: 26062441
[TBL] [Abstract][Full Text] [Related]
10. A novel KLF4/LDHA signaling pathway regulates aerobic glycolysis in and progression of pancreatic cancer.
Shi M; Cui J; Du J; Wei D; Jia Z; Zhang J; Zhu Z; Gao Y; Xie K
Clin Cancer Res; 2014 Aug; 20(16):4370-80. PubMed ID: 24947925
[TBL] [Abstract][Full Text] [Related]
11. miR‑199a‑3p/Sp1/LDHA axis controls aerobic glycolysis in testicular tumor cells.
Zhou S; Min Z; Sun K; Qu S; Zhou J; Duan H; Liu H; Liu X; Gong Z; Li D
Int J Mol Med; 2018 Oct; 42(4):2163-2174. PubMed ID: 30015851
[TBL] [Abstract][Full Text] [Related]
12. Functional inhibition of lactate dehydrogenase suppresses pancreatic adenocarcinoma progression.
Cheng CS; Tan HY; Wang N; Chen L; Meng Z; Chen Z; Feng Y
Clin Transl Med; 2021 Jun; 11(6):e467. PubMed ID: 34185423
[TBL] [Abstract][Full Text] [Related]
13. p53/Lactate dehydrogenase A axis negatively regulates aerobic glycolysis and tumor progression in breast cancer expressing wild-type p53.
Zhou Y; Niu W; Luo Y; Li H; Xie Y; Wang H; Liu Y; Fan S; Li Z; Xiong W; Li X; Ren C; Tan M; Li G; Zhou M
Cancer Sci; 2019 Mar; 110(3):939-949. PubMed ID: 30618169
[TBL] [Abstract][Full Text] [Related]
14. Double genetic disruption of lactate dehydrogenases A and B is required to ablate the "Warburg effect" restricting tumor growth to oxidative metabolism.
Ždralević M; Brand A; Di Ianni L; Dettmer K; Reinders J; Singer K; Peter K; Schnell A; Bruss C; Decking SM; Koehl G; Felipe-Abrio B; Durivault J; Bayer P; Evangelista M; O'Brien T; Oefner PJ; Renner K; Pouysségur J; Kreutz M
J Biol Chem; 2018 Oct; 293(41):15947-15961. PubMed ID: 30158244
[TBL] [Abstract][Full Text] [Related]
15. The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancer.
Xiao X; Huang X; Ye F; Chen B; Song C; Wen J; Zhang Z; Zheng G; Tang H; Xie X
Sci Rep; 2016 Feb; 6():21735. PubMed ID: 26902416
[TBL] [Abstract][Full Text] [Related]
16. FOXM1 promotes the warburg effect and pancreatic cancer progression via transactivation of LDHA expression.
Cui J; Shi M; Xie D; Wei D; Jia Z; Zheng S; Gao Y; Huang S; Xie K
Clin Cancer Res; 2014 May; 20(10):2595-606. PubMed ID: 24634381
[TBL] [Abstract][Full Text] [Related]
17. miR-200b is a key regulator of tumor progression and metabolism targeting lactate dehydrogenase A in human malignant glioma.
Hu S; Jiang Q; Luo D; Zhao L; Fu X; Chen Y; Song X; Li L; Zhao H; He Y; Peng B
Oncotarget; 2016 Jul; 7(30):48423-48431. PubMed ID: 27374173
[TBL] [Abstract][Full Text] [Related]
18. miR-383 inhibits ovarian cancer cell proliferation, invasion and aerobic glycolysis by targeting LDHA.
Han RL; Wang FP; Zhang PA; Zhou XY; Li Y
Neoplasma; 2017; 64(2):244-252. PubMed ID: 28043152
[TBL] [Abstract][Full Text] [Related]
19. PLCε promotes urinary bladder cancer cells proliferation through STAT3/LDHA pathway‑mediated glycolysis.
Cheng H; Hao Y; Gao Y; He Y; Luo C; Sun W; Yuan M; Wu X
Oncol Rep; 2019 May; 41(5):2844-2854. PubMed ID: 30864733
[TBL] [Abstract][Full Text] [Related]
20. MiR-34b-3 and miR-449a inhibit malignant progression of nasopharyngeal carcinoma by targeting lactate dehydrogenase A.
Li H; Li X; Ge X; Jia L; Zhang Z; Fang R; Yang J; Liu J; Peng S; Zhou M; Xiang J; Zeng Z; Zhou W; Xiong W; Xiao G; Fang L; Li GY; Li Z
Oncotarget; 2016 Aug; 7(34):54838-54851. PubMed ID: 27458165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
